🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The overall purpose of this study is to evaluate the safety and efficacy of...
Status
Withdrawn
Location
University of Wisconsin School of Medicine and Public Health
Start Date
2022-07
Trial ID
NCT04373603
Treatments Being Tested
"In this study, the investigators plan to evaluate muscle mass and pain rel...
Status
Completed
Location
Ji Yeong Kim
Start Date
2021-08-16
Trial ID
NCT05014945
Treatments Being Tested
The aim of this study is to evaluate the efficacy of tumescent solution on ...
Status
Completed
Location
Pgids Rohtak
Start Date
2025-03-23
Trial ID
NCT07436546
Eligible participants with newly diagnosed myeloma who are not considered e...
Status
Recruiting
Location
Gundersen Lutheran
Start Date
2026-09
Trial ID
NCT07285239
Shoulder, neck, back and temporal pain and herpes zoster pain are neuropath...
Status
Completed
Location
Huinuode Biotechnology Co., Ltd.
Start Date
2023-06-01
Trial ID
NCT05809700
Treatments Being Tested
The goal of this clinical trial is to examine the proportion of patients wi...
Status
Not Yet Recruiting
Location
University of South Florida, Carol and Frank Morsani Center for Advanced Healthcare
Start Date
2025-04-01
Trial ID
NCT06528392
Treatments Being Tested
This is a Phase IIIb, multinational, multicenter, randomized, open-label st...
Status
Completed
Location
Centro de Investigaciones Médicas y Desarrollo LC S.R.L
Start Date
2022-07-05
Trial ID
NCT05415215
The primary objectives of this study are to compare the difference in glyco...
Status
Completed
Location
For additional information regarding investigative sites for this trial, call (858) 794-8889 8 AM to 5 PM Mon-Fri Pacific Standard Time
Start Date
2013-03
Trial ID
NCT01848990
The purpose of this study is to show that subcutaneous (SC) administration ...
Status
Completed
Location
Dana Farber Cancer Institute
Start Date
2017-10-27
Trial ID
NCT03277105
This study is the study of the combination of PEGPH20 and Pembrolizumab (MK...
Status
Unknown
Location
Banner Health - MD Anderson Cancer Center
Start Date
2019-05-01
Trial ID
NCT03634332
Treatments Being Tested